Tanke Biosciences Corp
TNBI OTC
SEC CIK 1452011
Follow Tanke Biosciences
Weekly email: filings, results
Revenue, last year
$28.6M
+19.8% vs prior year
Net income
−$210.2K
+93.3% vs prior year
EPS, diluted
−$0.02
+91.7% vs prior year
Operating cash flow
−$1.2M
−132.4% vs prior year
Source: SEC XBRL filings · latest filing
- Revenue
- Net income
Show the numbers
| Year | Revenue | Net income |
|---|---|---|
| FY12 | $28.6M | −$210.2K |
| FY11 | $23.8M | −$3.1M |
| FY10 | $20.1M | $2.7M |
| FY09 | - | $2.6M |
| FY08 | - | - |
- Gross margin
- Operating margin
- Net margin
Show the numbers
| Year | Gross margin | Operating margin | Net margin |
|---|---|---|---|
| FY12 | 34.8% | 15.9% | −0.7% |
| FY11 | 36.8% | 7.3% | −13.2% |
| FY10 | 36.8% | 21.8% | 13.6% |
| FY09 | - | - | - |
| FY08 | - | - | - |
Show the numbers
| Year | Free cash flow |
|---|---|
| FY12 | −$2M |
| FY11 | $3M |
| FY10 | $4.3M |
| FY09 | - |
| FY08 | - |